New aspects in the pathogenesis and management of subacute thyroiditis.
Stasiak M, Lewiński A.
Rev Endocr Metab Disord. 2021 Dec;22(4):1027-1039. doi: 10.1007/s11154-021-09648-y. Epub 2021 May 5.
Factors affecting recurrence in subacute granulomatous thyroiditis.
Bahadir ÇT, Yilmaz M, Kiliçkan E.
Arch Endocrinol Metab. 2022 May 13;66(3):286-294. doi: 10.20945/2359-3997000000473. Epub 2022 May 12.
Identifying the Lowest Effective Initial Dose of Prednisolone for the Treatment of Subacute Granulomatous Thyroiditis: A Systematic Review and Meta-Analysis.
Soltani A, Nourani F, Roudsari SB, Jouybari L, Fathi M, Haghighat S, Hadavi M, Aletaha A.
Curr Rev Clin Exp Pharmacol. 2022;17(2):135-143. doi: 10.2174/2772432816666211012092112.
[Inflammatory diseases of the thyroid gland].
Synoracki S, Ting S, Schmid KW.
Pathologe. 2016 May;37(3):215-23. doi: 10.1007/s00292-016-0157-9.
Subacute thyroiditis.
FRASER R, HARRISON RJ.
Lancet. 1952 Feb 23;1(6704):382-6. doi: 10.1016/s0140-6736(52)90002-0.
Subacute thyroiditis.
Greer MA.
West J Med. 1991 Jul;155(1):83.
Subacute Thyroiditis in COVID-19 Patients.
Seyed Resuli A, Bezgal M.
Ear Nose Throat J. 2022 Sep;101(8):501-505. doi: 10.1177/01455613211012114. Epub 2021 May 11.
Subacute thyroiditis after COVID-19.
Tjønnfjord E, Moe RB, Ghanima W, Aballi S.
Tidsskr Nor Laegeforen. 2021 Jun 28;141(10). doi: 10.4045/tidsskr.21.0169. Print 2021 Jun 29.
Subacute thyroiditis following COVID-19: A systematic review.
Meftah E, Rahmati R, Zari Meidani F, Khodadadi S, Chitzan-Zadeh K, Esfahanian F, Afshar S.
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126637. doi: 10.3389/fendo.2023.1126637. eCollection 2023.
Subacute thyroiditis following COVID-19 infection.
de la Higuera López-Frías M, Perdomo CM, Galofré JC.
Rev Clin Esp (Barc). 2021 Jun-Jul;221(6):370-372. doi: 10.1016/j.rceng.2021.01.002. Epub 2021 Mar 26.
